Panama Expands Affordable Drug Program
In a significant move for public health, Panama is substantially broadening access to affordable medications. This expansion of the low-cost drug program aims to alleviate the financial burden on citizens struggling with chronic and common illnesses by dramatically reducing pharmaceutical costs.
Presidential Announcement
President José Raúl Mulino announced a considerable expansion of the medication program on Thursday, June 12th. An additional 80 drugs will now be available, joining the initial 60 previously offered. In total, Panamanians can now obtain 140 essential medicines with discounts between 52% and 95%.
“We are expanding access to necessary treatments at prices people can actually afford,”
—President Mulino
The president also stated that there are now 110 pharmacies participating in the program, with further expansions planned. This initiative directly addresses long-standing concerns regarding drug prices in Panama.
Addressing High Drug Costs
For years, Panama has faced considerable public criticism due to high drug prices, which are among the highest in Latin America. The lack of adequate regulation, the dominance of certain importers and distributors, and limited market options have made basic medications unaffordable, particularly for those with chronic conditions and low incomes. This new program aims to rectify these issues.
The initial phase of the program, launched in mid-May, offered 60 medications through pharmacies operated by the Ministry of Health and the Social Security Fund, with discounts up to 80%. This included treatments for hypertension, diabetes, respiratory illnesses, and mental health.
Medications and Discounts
The expanded list includes treatments such as Amlodipine, Atenolol, Enalapril, and others. The added 80 drugs cover a wider range of treatments including antibiotics, antidiabetics, and painkillers. Examples include Amoxicillin, Calamine, and Clindamycin.
Significant price reductions are available. For instance, 10 ml NPH insulin, which typically costs 25 balboas, is now just $2.50, a 90% discount. Similarly, the price of 500 mg cephalexin has dropped to 10 cents, an 88% reduction. According to a 2024 report by the World Health Organization, access to affordable medication can significantly improve public health outcomes (WHO).
Future Plans
President Mulino mentioned plans to expand the access network further, though details on home delivery, collaborations with private pharmacies, or rural area distribution are yet to be announced. The initiative is a critical step towards improving healthcare affordability in Panama.
